Evidence map›Paper›PMID 38792040›Full record

ReviewMolecules (Basel, Switzerland)2024

Advances in Extraction Protocols, Degradation Methods, and Bioactivities of Proanthocyanidins.

Lishan Liang, Yingjie Liu, Liyan Wu, Luo Weng, Honghao Qiu, Wenting Zhong, Fanxin Meng

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Fractionation-Based Modeling of Hawthorn (Molecules (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lishan LiangCollege of Pharmacy and Food Science, Zhuhai College of Science and Technology, Zhuhai 519041, China.ORCID 0009-0003-0208-2062
Yingjie LiuCollege of Pharmacy and Food Science, Zhuhai College of Science and Technology, Zhuhai 519041, China.
Liyan WuCollege of Pharmacy and Food Science, Zhuhai College of Science and Technology, Zhuhai 519041, China.
Luo WengCollege of Pharmacy and Food Science, Zhuhai College of Science and Technology, Zhuhai 519041, China.
Honghao QiuCollege of Pharmacy and Food Science, Zhuhai College of Science and Technology, Zhuhai 519041, China.
Wenting ZhongCollege of Pharmacy and Food Science, Zhuhai College of Science and Technology, Zhuhai 519041, China.
Fanxin MengCollege of Pharmacy and Food Science, Zhuhai College of Science and Technology, Zhuhai 519041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proanthocyanidins, natural polyphenolic compounds abundantly present in plants, exhibit diverse bioactivities, including antioxidative, anti-inflammatory, and antibacterial effects. These bioactivities are intricately linked to the degree of polymerization of these compounds. Through a comprehensive analysis of recent domestic and international research, this article synthesizes the latest advancements in the extraction process, degradation methods, as well as the biological activities and underlying mechanisms of proanthocyanidins. Furthermore, future research endeavors should prioritize the refinement of extraction techniques, the elucidation of bioactive mechanisms, and the development of formulations with enhanced potency. This will maximize the utilization of proanthocyanidins across diverse applications.

Indexed as

Anti-Inflammatory AgentsAntioxidantsProanthocyanidinsAnti-Bacterial AgentsPlant ExtractsAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsPlant ExtractsProanthocyanidinsbioactivitiesdegradationextractionflavan-3-olsproanthocyanidins

Identifiers

PMID38792040
PMCPMC11123784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.